Outlook Therapeutics Files 8-K
Ticker: OTLK · Form: 8-K · Filed: Nov 27, 2024 · CIK: 1649989
| Field | Detail |
|---|---|
| Company | Outlook Therapeutics, Inc. (OTLK) |
| Form Type | 8-K |
| Filed Date | Nov 27, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-event, financials
Related Tickers: OTLK
TL;DR
OTLK filed an 8-K on Nov 27, 2024. Check it for corporate updates.
AI Summary
Outlook Therapeutics, Inc. filed an 8-K on November 27, 2024, reporting other events and financial statements. The company, formerly known as Oncobiologics, Inc., is incorporated in Delaware and has its principal executive offices in Iselin, New Jersey.
Why It Matters
This filing provides an update on the company's corporate events and financial status, which is crucial for investors to assess the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing of corporate information and financial statements, not indicating immediate significant operational or financial changes.
Key Players & Entities
- Outlook Therapeutics, Inc. (company) — Registrant
- Oncobiologics, Inc. (company) — Former company name
- November 27, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Iselin, New Jersey (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of November 27, 2024.
What was Outlook Therapeutics, Inc. formerly known as?
Outlook Therapeutics, Inc. was formerly known as Oncobiologics, Inc.
In which state is Outlook Therapeutics, Inc. incorporated?
Outlook Therapeutics, Inc. is incorporated in Delaware.
Where are the principal executive offices of Outlook Therapeutics, Inc. located?
The principal executive offices of Outlook Therapeutics, Inc. are located at 111 S. Wood Avenue, Unit #100, Iselin, New Jersey 08830.
What is the IRS Employer Identification Number for Outlook Therapeutics, Inc.?
The IRS Employer Identification Number for Outlook Therapeutics, Inc. is 38-3982704.
Filing Stats: 410 words · 2 min read · ~1 pages · Grade level 10.1 · Accepted 2024-11-27 12:26:46
Filing Documents
- tm2429443d1_8k.htm (8-K) — 22KB
- tm2429443d1_ex99-1.htm (EX-99.1) — 19KB
- tm2429443d1_ex99-1img01.jpg (GRAPHIC) — 8KB
- 0001104659-24-123554.txt ( ) — 229KB
- otlk-20241127.xsd (EX-101.SCH) — 3KB
- otlk-20241127_lab.xml (EX-101.LAB) — 33KB
- otlk-20241127_pre.xml (EX-101.PRE) — 22KB
- tm2429443d1_8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated November 27, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Outlook Therapeutics, Inc. Date: November 27, 2024 By: /s/ Lawrence A. Kenyon Lawrence A. Kenyon Chief Financial Officer